Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * availability to participate during the entire study, and ability to follow study protocol strictly. * consent to supply personal contact information, such as telephone numbers, address and other information so the research team may contact the participant (for example, in case the participant fails to attend a scheduled visit without previous notice) * ability to understand and sign the volunteered and informed consent form, and ability to fill in the adverse events journal at home, according to the evaluation of the principal investigator ou delegated research team members. * understanding the impossibility of participating in another clinical trial while participating in this clinical trial. * ability to fill out the adverse events journal at home

inclusion criteria: * availability to participate during the entire study, and ability to follow study protocol strictly. * consent to supply personal contact information, such as telephone numbers, address and other information so the research team may contact the participant (for example, in case the participant fails to attend a scheduled visit without previous notice) * ability to understand and sign the volunteered and informed consent form, and ability to fill in the adverse events journal at home, according to the evaluation of the principal investigator ou delegated research team members. * understanding the impossibility of participating in another clinical trial while participating in this clinical trial. * ability to fill out the adverse events journal at home

Dec. 16, 2021, 2 a.m. usa

inclusion criteria: availability to participate during the entire study, and ability to follow study protocol strictly. consent to supply personal contact information, such as telephone numbers, address and other information so the research team may contact the participant (for example, in case the participant fails to attend a scheduled visit without previous notice) ability to understand and sign the volunteered and informed consent form, and ability to fill in the adverse events journal at home, according to the evaluation of the principal investigator ou delegated research team members. understanding the impossibility of participating in another clinical trial while participating in this clinical trial. ability to fill out the adverse events journal at home

inclusion criteria: availability to participate during the entire study, and ability to follow study protocol strictly. consent to supply personal contact information, such as telephone numbers, address and other information so the research team may contact the participant (for example, in case the participant fails to attend a scheduled visit without previous notice) ability to understand and sign the volunteered and informed consent form, and ability to fill in the adverse events journal at home, according to the evaluation of the principal investigator ou delegated research team members. understanding the impossibility of participating in another clinical trial while participating in this clinical trial. ability to fill out the adverse events journal at home